Cargando…
Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent
The efficacious treatment of hepatocellular carcinoma (HCC) remains a challenge, partially being attributed to intrinsic chemoresistance. Previous reports have observed increased TFF3 expression in HCC. Herein, we investigated the functional role of TFF3 in progression of HCC, and in both intrinsic...
Autores principales: | You, Ming-Liang, Chen, Yi-Jun, Chong, Qing-Yun, Wu, Ming-Ming, Pandey, Vijay, Chen, Ru-Mei, Liu, Liang, Ma, Lan, Wu, Zheng-Sheng, Zhu, Tao, Lobie, Peter E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503616/ https://www.ncbi.nlm.nih.gov/pubmed/28445151 http://dx.doi.org/10.18632/oncotarget.16950 |
Ejemplares similares
-
Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells
por: Pandey, Vijay, et al.
Publicado: (2017) -
Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
por: Chong, Qing-Yun, et al.
Publicado: (2017) -
Trefoil Factor 3 as a Novel Biomarker to Distinguish Between Adenocarcinoma and Squamous Cell Carcinoma
por: Wang, Xiao-Nan, et al.
Publicado: (2015) -
Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma
por: Pandey, Vijay, et al.
Publicado: (2014) -
A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma
por: Zhang, Mengyi, et al.
Publicado: (2019)